Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of rhBMP-7 (Osigraft) for reconstruction of alveolar cleft
2005-004392-38Phase 2Terminated
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Jan 2006
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bone morphogenetic protein 7 in cleft alveolus, sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Radiographic assessment of newly formed bone at 6 months. Started Jan 2006; status: terminated.
02
Drugs
bone morphogenetic protein 7
03
Conditions
cleft alveolus
Beyond the preview
Go deeper on 2005-004392-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004392-38.